Business Description
Abbott India Ltd
ISIN : INE358A01014
Compare
Compare
Traded in other countries / regions
ABBOTINDIA.India IPO Date
1992-02-03Description
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 22.02 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 98.53 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 26.3 | |||||
| Beneish M-Score | 1.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.3 | |||||
| 3-Year EBITDA Growth Rate | 16 | |||||
| 3-Year EPS without NRI Growth Rate | 17 | |||||
| 3-Year FCF Growth Rate | 12.1 | |||||
| 3-Year Book Growth Rate | 9.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.03 | |||||
| 9-Day RSI | 57 | |||||
| 14-Day RSI | 51.11 | |||||
| 6-1 Month Momentum % | 21.79 | |||||
| 12-1 Month Momentum % | 21.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.37 | |||||
| Quick Ratio | 1.96 | |||||
| Cash Ratio | 1.62 | |||||
| Days Inventory | 72.56 | |||||
| Days Sales Outstanding | 21.75 | |||||
| Days Payable | 100.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.68 | |||||
| Dividend Payout Ratio | 0.33 | |||||
| 3-Year Dividend Growth Rate | 42.6 | |||||
| Forward Dividend Yield % | 0.68 | |||||
| 5-Year Yield-on-Cost % | 2.77 | |||||
| Shareholder Yield % | 0.77 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.8 | |||||
| Operating Margin % | 23.39 | |||||
| Net Margin % | 19.92 | |||||
| FCF Margin % | 14.94 | |||||
| ROE % | 38.14 | |||||
| ROA % | 26.09 | |||||
| ROIC % | 58.93 | |||||
| ROC (Joel Greenblatt) % | 655.04 | |||||
| ROCE % | 48.86 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 47.98 | |||||
| PE Ratio without NRI | 47.98 | |||||
| Shiller PE Ratio | 81.31 | |||||
| Price-to-Owner-Earnings | 53.28 | |||||
| PEG Ratio | 2.91 | |||||
| PS Ratio | 9.56 | |||||
| PB Ratio | 17.68 | |||||
| Price-to-Tangible-Book | 18.22 | |||||
| Price-to-Free-Cash-Flow | 63.96 | |||||
| Price-to-Operating-Cash-Flow | 61.52 | |||||
| EV-to-EBIT | 35.23 | |||||
| EV-to-EBITDA | 33.7 | |||||
| EV-to-Revenue | 9.49 | |||||
| EV-to-FCF | 61.72 | |||||
| Price-to-Projected-FCF | 5.14 | |||||
| Price-to-DCF (Earnings Based) | 2.07 | |||||
| Price-to-DCF (FCF Based) | 2.76 | |||||
| Price-to-Median-PS-Value | 1.89 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.91 | |||||
| Price-to-Graham-Number | 6.51 | |||||
| Price-to-Net-Current-Asset-Value | 36.62 | |||||
| Price-to-Net-Cash | 92.85 | |||||
| Earnings Yield (Greenblatt) % | 2.83 | |||||
| FCF Yield % | 1.52 | |||||
| Forward Rate of Return (Yacktman) % | 17.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abbott India Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 57,513.6 | ||
| EPS (TTM) (₹) | 539.09 | ||
| Beta | 0.14 | ||
| Volatility % | 21.6 | ||
| 14-Day RSI | 51.11 | ||
| 14-Day ATR (₹) | 568.406644 | ||
| 20-Day SMA (₹) | 26317.6175 | ||
| 12-1 Month Momentum % | 21.84 | ||
| 52-Week Range (₹) | 20594.25 - 29628.15 | ||
| Shares Outstanding (Mil) | 21.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abbott India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abbott India Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Abbott India Ltd Frequently Asked Questions
What is Abbott India Ltd(BOM:500488)'s stock price today?
The current price of BOM:500488 is ₹26604.35. The 52 week high of BOM:500488 is ₹29628.15 and 52 week low is ₹20594.25.
When is next earnings date of Abbott India Ltd(BOM:500488)?
The next earnings date of Abbott India Ltd(BOM:500488) is .
Does Abbott India Ltd(BOM:500488) pay dividends? If so, how much?
The Dividend Yield %  of Abbott India Ltd(BOM:500488) is 0.68% (As of Today), Highest Dividend Payout Ratio of Abbott India Ltd(BOM:500488) was 0.33. The lowest was 0.18. And the median was 0.26. The  Forward Dividend Yield % of Abbott India Ltd(BOM:500488) is 0.68%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers